Skip to main content
Quest Diagnostics

A Draft Framework for Classification and Reporting of Risk Alleles from the ClinGen Low-Penetrance/Risk Allele Working Group


AMP 2021: Association for Molecular Pathology
Conference cancelled, but poster available virtually, Nov 16-20, 2021

A Draft Framework for Classification and Reporting of Risk Alleles from the ClinGen Low-Penetrance/Risk Allele Working Group

Authors: Lebo MS, Bayrak-Toydemir P, Coe B, Dereani T, Garcia J, Gollob MH, Jobanputra V, McGoldrick K, Pollin TI, Qian E, Rehm HL, Schilit SLP, Sergouniotis PI, Steeves M, Tvrdik T, Maston G, Schmidt RJ

Specialties: Genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.